CLPT ClearPoint Neuro, Inc.
Healthcare$11.63+0.00%OpenMarket Cap: $348.8M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
17.94
P/S
8.45
EV/EBITDA
-15.50
DCF Value
$-14.28
FCF Yield
-7.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
61.8%
Operating Margin
-65.2%
Net Margin
-71.6%
ROE
-141.0%
ROA
-31.1%
ROIC
-31.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $12.1M | 62.2% | $-8.5M | $-9.6M | $— | — |
| Q4 null | $10.4M | 61.5% | $-7.0M | $-7.8M | $— | — |
| FY null | $37.0M | 61.4% | $-24.2M | $-25.5M | $— | — |
| Q3 null | $8.9M | 63.2% | $-5.3M | $-5.9M | $— | — |
| Q2 null | $9.2M | 60.3% | $-5.7M | $-5.8M | $— | — |
| Q1 null | $8.5M | 60.5% | $-6.2M | $-6.0M | $— | — |
| Q4 null | $7.8M | 61.3% | $-5.6M | $-5.4M | $— | — |
| FY null | $31.4M | 60.9% | $-19.7M | $-18.9M | $— | — |
| Q3 null | $8.1M | 59.7% | $-5.2M | $-5.0M | $— | — |
| Q2 null | $7.9M | 63.5% | $-4.7M | $-4.4M | $— | — |
| Q1 null | $7.6M | 59.2% | $-4.2M | $-4.1M | $— | — |
| Q4 2023 | $6.8M | 58.9% | $-4.7M | $-4.6M | $-0.19 | — |